Shinva Medical Instrument (600587.SH) obtained Class II medical device registration certificates for two products.
Xinhua Medical (600587.SH) issued an announcement that the company recently received the "..." issued by the Shandong Provincial Drug Administration.
Shinva Medical Instrument (600587.SH) announced that the company recently received the "Medical Device Registration Certificate" issued by the Shandong Provincial Food and Drug Administration, involving products: "Dental Implant Mobile Phone" and "Mobile Laser Simulation Positioning System".
The announcement stated that the dental implant mobile phone product has been successfully registered, forming a deep integration with the company's already existing dental implant machine products, enriching the company's dental implant product line, providing a more complete dental implant solution for clinical use, and promoting the company's efficient development in the field of dental implantation. The approval for the marketing of the Mobile Laser Simulation Positioning System enhances the company's competitiveness in radiation therapy positioning products, its high accuracy and reliability can meet medical institutions' demand for precise radiotherapy, improve treatment effectiveness, and enhance the company's brand awareness in the field of radiation therapy equipment.
Related Articles

US Stock Market Move | ACCL.US, a company controlled by Zhuo Yuan, has landed on the US stock market with a 1.75% increase in trading at the opening.

US Stock Market Move | NVIDIA Corporation holds Concept Stock Coreweave (CRWV.US), which fell more than 7%.

US Stock Market Move | Reach a $1.085 billion cooperation agreement with domestic and foreign pharmaceutical companies, Rani Therapeutics (RANI.US) soars over 265%.
US Stock Market Move | ACCL.US, a company controlled by Zhuo Yuan, has landed on the US stock market with a 1.75% increase in trading at the opening.

US Stock Market Move | NVIDIA Corporation holds Concept Stock Coreweave (CRWV.US), which fell more than 7%.

US Stock Market Move | Reach a $1.085 billion cooperation agreement with domestic and foreign pharmaceutical companies, Rani Therapeutics (RANI.US) soars over 265%.

RECOMMEND